Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
U.S. Dermatology Partners is a large U.S. dermatology care network that provides medical, surgical, and cosmetic dermatology services through a coordinated multi-state physician practice platform. The company operates more than 130 locations across nine states and treats more than 2 million patients annually. Its offering spans general dermatology, skin cancer diagnosis and treatment, Mohs surgery, cosmetic dermatology, dermatopathology, and clinical research support. U.S. Dermatology Partners appears to function primarily as a care-delivery and practice-management organization rather than a drug-development biotech company. The business has been backed by private equity and is reported by third-party databases as having been acquired by Abry Partners in 2016.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on U.S. Dermatology Partners.